Pharmaceutical formulations with improved bioavailability

Details for Australian Patent Application No. 2003231777 (hide)

Owner Supernus Pharmaceuticals, Inc.

Inventors Burnside, Beth A; Shojaei, Amir H; Flanner, Henry; Ibrahim, Scott

Agent Spruson & Ferguson

Pub. Number AU-B-2003231777

PCT Number PCT/US03/13099

PCT Pub. Number WO2004/000280

Priority 60/375,803 29.04.02 US

Filing date 29 April 2003

Wipo publication date 6 January 2004

Acceptance publication date 18 December 2008

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/32 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/34 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/38 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/375,803 29.04.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003231777

28 July 2005 Amendment Made

  The nature of the amendment is: Amend the inventors to read Flanner, Henry, Ibrahim, Scott, Shojaei, Amir H and Burnside, Beth A

18 December 2008 Assignment before Grant

  Shire Laboratories, Inc. The application has been assigned to Supernus Pharmaceuticals, Inc.

18 December 2008 Application Accepted

  Published as AU-B-2003231777

23 April 2009 Standard Patent Sealed

11 June 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Apr 2009. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

29 October 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Apr 2009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003231778-CONDUITS FOR MAINTAINING OPENINGS IN TISSUE

2003231776-System and method for identifying data streams associated with medical equipment